Industry

Voting Cards Reveal that Over 50% of Shareholders Excluding the Founding Family and Related Parties Voted For Oasis’s EGM Proposals and Against Mr. Akihiro Kobayashi’s Renomination at the AGM

(Securities Code: 4967 JT) *Oasis’s proposals at the EGM had over majority approval, when calculated on the basis of excluding the shares owned by the founding family and its related parties (Majority of Minority, “MoM”) *The Special Resolution (Agenda 1) at the AGM, which called for amendments to Kobayashi Pharma’s Articles of Incorporation, received supermajority … [Read more…]

Manifest MedEx Adds Health-Related Social Services (HRSS) Information to Its Claims and Clinical Data Exchange Network

Social services organizations can now join California’s largest nonprofit health data network to better coordinate whole person care with local hospitals and health plans RIVERSIDE, Calif.–(BUSINESS WIRE)–Manifest MedEx (MX) announced today that health-related social services (HRSS) organizations can now connect and exchange health and HRSS information through its nonprofit health data network to help those … [Read more…]

Enanta Pharmaceuticals’ Partner AbbVie Receives U.S. FDA Approval of an Expanded Indication for MAVYRET® (glecaprevir/pibrentasvir) as the First and Only Treatment for People with Acute Hepatitis C Virus

MAVYRET® (glecaprevir/pibrentasvir) is Now the Only Direct Acting Antiviral Therapy Approved to Treat Patients with Acute Hepatitis C Virus (HCV) in Eight Weeks with a 96% Cure Rate1*† FDA Approval Now Allows Providers to Treat HCV Patients Immediately at Time of Diagnosis If Left Untreated, Patients with Acute HCV Could Progress to Chronic Disease, Including … [Read more…]

Guy’s and St Thomas’ Collaborates With Leading AI Companies to Transform Healthcare Delivery

Initiative includes General Catalyst, NVIDIA, Hippocratic AI, and Sword Health LONDON–(BUSINESS WIRE)–#GenAI–Guy’s and St Thomas’ NHS Foundation Trust has announced the launch of the Proactive & Accessible Transformation of Healthcare (PATH) initiative in collaboration with General Catalyst, NVIDIA, Hippocratic AI, and Sword Health. PATH brings together leading technology companies to explore comprehensive solutions to deliver … [Read more…]

Bristol Myers Squibb Presents Late-Breaking Data from Pivotal Phase 3 POETYK PsA-1 Trial Demonstrating Superiority of Sotyktu (deucravacitinib) Compared with Placebo in Adults with Psoriatic Arthritis

Significantly more patients treated with Sotyktu achieved improvements in joint and skin symptoms, measures of disease activity and quality of life at Week 16 in POETYK PsA-1 New data from POETYK PsA-2 trial demonstrated that meaningful clinical responses continued to improve and outcomes were maintained through Week 52 Sotyktu demonstrated safety consistent with the established … [Read more…]

Bayer and Broad Institute Extend Research Collaboration to Develop New Cardiovascular Therapies

Focus on joint discovery of novel therapeutic approaches based on findings in human genomics research related to cardiovascular diseases Current efforts focused on treatment options for specific forms of cardiovascular disease such as dilated cardiomyopathy Phase I clinical study in healthy volunteers for development of new treatment for patients with atrial fibrillation recently initiated Extended … [Read more…]

Omega Announces Pricing of Its $600,000,000 Senior Notes Offering

HUNT VALLEY, Md.–(BUSINESS WIRE)–Omega Healthcare Investors, Inc. (NYSE: OHI) (“Omega”) today announced that it priced an underwritten public offering of $600,000,000 aggregate principal amount of 5.200% Senior Notes due 2030 (the “2030 Notes”). The settlement of this offering is expected to occur on June 20, 2025, subject to customary closing conditions. Omega intends to use … [Read more…]

Global Healthy Living Foundation Says Vaccine Committee Firings Before Respiratory Virus Season Creates High Risk Of Illness In the Chronic Disease Community

HHS Interrupts “The Most Cost-Beneficial Intervention In Healthcare” UPPER NYACK, N.Y.–(BUSINESS WIRE)–Yesterday, the Secretary of Health and Human Services (HHS) removed all sitting members of the Advisory Committee on Immunization Practices (ACIP), the expert panel that advises the Centers for Disease Control and Prevention (CDC) on vaccine use. While the groups such as the Global … [Read more…]

Top Players Shaping the Future of the Preimplantation Genetic Testing Market – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Preimplantation Genetic Testing Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F” has been added to ResearchAndMarkets.com’s offering. The Preimplantation Genetic Testing Market was valued at USD 0.66 Billion in 2024 and is expected to reach USD 1.05 Billion by 2030, rising at a CAGR of 8.20%. Preimplantation Genetic Testing (PGT) … [Read more…]

Enhanced Genomics Appoints Dietrich Stephan, Ph.D. as Chair of the Board to Lead Ambitious Growth Strategy

Appointment strengthens leadership team to drive strategy focused on harnessing 3D multi-omics to identify high-confidence, high-value therapeutic targets, to accelerate drug discovery CAMBRIDGE, England–(BUSINESS WIRE)–Enhanced Genomics (‘Enhanced’ or ‘the Company’), the biotechnology company pioneering 3D multi-omics to rapidly identify high-confidence, genetically validated drug targets for common diseases, today announced the appointment of Dietrich Stephan, Ph.D. … [Read more…]